Insiders Lipocine Inc.

Equities

LPCN

US53630X2036

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
5.32 ^USD	+1.53%		+13.68%	+90.68%

09/05	Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M	MT
09/05	Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lipocine Inc. Announces Senior Leadership Appointments to Advance Its CNS-Focused Pipeline	03/22/03	CI
Lipocine Inc. Announces Board Appointments	11/22/11	CI
Clene Names Morgan Brown as Finance Chief	01/22/01	MT
Lipocine Chief Financial Officer is Retiring	22/22/22	MT
Lipocine Inc. Announces Executive Changes	22/22/22	CI
Lipocine Inc. Announces Resignation of Gregory Bass as Executive Vice President and Chief Commercial Officer, Effective on August 27, 2018	18/18/18	CI
Lipocine Inc. Terminates the Employment of Jyrki Mattila as Executive Vice President and Chief Business Officer	08/17/08	CI
Lipocine Inc. Announces the Promotion of Gregory Bass to Executive Vice President and Chief Commercial Officer	15/17/15	CI
Lipocine Appoints Jyrki Mattila as Executive Vice President and Chief Business Officer	19/15/19	CI
Lipocine Inc. Announces Board Resignations	15/14/15	CI
Lipocine Inc. Announces Changes to the Board of Directors	08/14/08	CI
Lipocine Inc. Appoints Morgan Brown as Executive Vice President and Chief Financial Officer	16/13/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW